SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001598
Filing Date
2024-01-19
Accepted
2024-01-19 16:25:05
Documents
1
Period of Report
2024-01-18

Document Format Files

Seq Description Document Type Size
1 form4-01192024_090158.html 4  
1 form4-01192024_090158.xml 4 5839
  Complete submission text file 0001415889-24-001598.txt   7558
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Fischer Seth H. Z. (Reporting) CIK: 0001573553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 24545919